iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by iTeos Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for iTeos Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rhoads Ann D | Director | – | Aug 29, 2025 | 0 |
| Hallal David | Director | 0 | Aug 29, 2025 | 0 |
| Gall Matthew | Chief Financial Officer | 0 | Aug 29, 2025 | 0 |
| Detheux Michel | Chief Executive Officer | 0Indirect | Aug 29, 2025 | 0 |
| Call Matthew | Chief Operating Officer | 0 | Aug 29, 2025 | 0 |
| McGrath Yvonne | Chief Scientific Officer | 0 | Aug 29, 2025 | 0 |
| Lee David K | Director | – | Aug 29, 2025 | 0 |
| Feltquate David | Chief Medical Officer | 0 | Aug 29, 2025 | 0 |
| EcoR1 Capital, LLC | 10% Owner | 10,688,978Indirect | May 16, 2025 | 0 |
| Gadicke Ansbert | Other: Former 10% Owner | 3,452,797Indirect | May 15, 2025 | 0 |
| MPM BioImpact LLC | Other: Former 10% Owner | 3,452,797Indirect | May 15, 2025 | 0 |
| UBS Oncology Impact Fund L.P. | Other: Former 10% Owner | 3,452,797Indirect | May 15, 2025 | 0 |
| Oncology Impact Fund (Cayman) Management L.P. | Other: Former 10% Owner | 3,452,797Indirect | May 15, 2025 | 0 |
| MPM Bioventures 2018, L.P. | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2018 GP LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2018 LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| Evnin Luke | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| Foley Todd | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2014, L.P. | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2014 (B), L.P. | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM Asset Management Investors BV2014 LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM Bioventures 2018 (B), L.P. | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM Asset Management Investors BV2018 LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2014 LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| MPM BioVentures 2014 GP LLC | Other: Former 10% Owner | 2,108,594Indirect | May 15, 2025 | 0 |
| Van Hauwermeiren Timothy | Director | 22,346 | May 14, 2025 | 0 |
| Davis Aaron I. | Director | 2,946,915 | Jun 13, 2024 | 0 |
| Ho Tony W | Director | – | Jun 13, 2024 | 0 |
| Iannone Robert | Director | – | Jun 13, 2024 | 0 |
| DeSimone Jill | Director | – | Jun 13, 2024 | 0 |
| Lewis Joseph | Other: See remarks | 2,946,915 | May 14, 2024 | 0 |
| Boxer Asset Management Inc. | Other: See remarks | 2,946,915 | May 14, 2024 | 0 |
| Boxer Capital, LLC | Other: See remarks | 2,946,915 | May 14, 2024 | 0 |
| RA Capital Healthcare Fund LP | Other: Former 10% Owner | 2,545,510Indirect | May 14, 2024 | 0 |
| Ra Capital Management, L.P. | Other: Former 10% Owner | 2,545,510Indirect | May 14, 2024 | 0 |
| Kolchinsky Peter | Other: Former 10% Owner | 2,545,510Indirect | May 14, 2024 | 0 |
| Shah Rajeev M. | Other: Former 10% Owner | 2,545,510Indirect | May 14, 2024 | 0 |
| DiRocco Derek | Director | – | Jun 15, 2023 | 0 |
| Lager Joanne Jenkins | Chief Medical Officer | 0 | Mar 10, 2023 | 0 |
| Biniszkiewicz Detlev | Director | 0 | Jun 10, 2022 | 0 |
| Roden Matthew | Director | – | Jun 10, 2022 | 0 |
| MVA Investors, LLC | 10% Owner | 0 | Jan 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 (view filing)6:56 PM ET | Nov 30-Dec 2 | 2 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −83.5K | $34.47 | −$2.88M | −2.8%2.94M after | 7 lotsDuplicate filing |
| Dec 7, 2021 (view filing)6:33 PM ET | Dec 3-7 | 4 days | Gadicke Ansbert and 3 others10% Owner | SSale | −83.4K | $33.73 | −$2.81M | −1.7%4.73M after | 9 lots |
| Dec 7, 2021 (view filing)6:35 PM ET | Dec 3-7 | 4 days | Evnin Luke and 8 others10% Owner | SSale | −49.8K | $33.73 | −$1.68M | −1.7%2.89M after | 9 lots |
| Dec 7, 2021 (view filing)6:36 PM ET | Dec 3-7 | 4 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −49.8K | $33.73 | −$1.68M | −1.7%2.89M after | 9 lotsDuplicate filing |
| Dec 10, 2021 (view filing) | Dec 10 | Same day | Lager Joanne JenkinsChief Medical Officer | SSale | −3.50K | $34.50 | −$120.8K | −100.0%0 after | |
| Dec 17, 2021 (view filing) | Dec 17 | Same day | Lager Joanne JenkinsChief Medical Officer | SSale | −7.00K | $41.00 | −$287.0K | −100.0%0 after | |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Hallal DavidDirector | SSale | −50.0K | $43.57 | −$2.18M | −100.0%0 after | |
| Dec 22, 2021 (view filing) | Dec 20-22 | 2 days | Detheux MichelChief Executive Officer | SSale | −44.5K | $44.54 | −$1.98M | −41.1%63.7K after | 7 lots |
| Dec 28, 2021 (view filing) | Dec 27 | 1 day | Gall MatthewChief Financial Officer | SSale | −5.00K | $46.45 | −$232.3K | −25.7%14.4K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Biniszkiewicz DetlevDirector | SSale | −3.50K | $51.90 | −$181.7K | −100.0%0 after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Lager Joanne JenkinsChief Medical Officer | SSale | −7.00K | $51.90 | −$363.3K | −100.0%0 after | |
| Jan 5, 2022 (view filing)9:20 PM ET | Jan 3-4 | 2 days | Boxer Capital, LLC and 4 othersDirector, 10% Owner | SSale | −700.0K | $46.54 | −$32.6M | −100.0%0 after | 14 lots |
| Jan 6, 2022 (view filing)4:12 PM ET | Jan 4-5 | 2 days | Gadicke Ansbert and 3 others10% Owner | SSale | −245.5K | $42.58 | −$10.5M | −5.2%4.48M after | 5 lots |
| Jan 6, 2022 (view filing)4:12 PM ET | Jan 4-5 | 2 days | Evnin Luke and 8 others10% Owner | SSale | −146.7K | $42.58 | −$6.25M | −5.1%2.74M after | 5 lots |
| Jan 6, 2022 (view filing)4:13 PM ET | Jan 4-5 | 2 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −146.7K | $42.58 | −$6.25M | −5.1%2.74M after | 5 lotsDuplicate filing |
| Jan 18, 2022 (view filing) | Jan 14 | 4 days | Lager Joanne JenkinsChief Medical Officer | SSale | −3.50K | $39.32 | −$137.6K | −100.0%0 after | 2 lots |
| Jan 26, 2022 (view filing) | Jan 25 | 1 day | Detheux MichelChief Executive Officer | SSale | −14.5K | $35.68 | −$517.4K | −22.8%49.2K after | 2 lots |
| Feb 14, 2022 (view filing) | Feb 11 | 3 days | Lager Joanne JenkinsChief Medical Officer | SSale | −3.50K | $35.85 | −$125.5K | −100.0%0 after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Detheux MichelChief Executive Officer | SSale | −14.5K | $34.34 | −$497.9K | −29.5%34.7K after | 2 lots |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | McGrath YvonneChief Scientific Officer | SSale | −10.0K | $36.76 | −$367.6K | −100.0%0 after | |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Lager Joanne JenkinsChief Medical Officer | SSale | −3.50K | $36.01 | −$126.0K | −100.0%0 after | |
| Mar 18, 2022 (view filing)9:00 PM ET | Mar 17 | 1 day | Lewis Joseph and 2 others10% Owner | SSale | −575.2K | $35.25 | −$20.3M | −15.5%3.14M after | |
| Mar 22, 2022 (view filing) | Mar 22 | Same day | Detheux MichelChief Executive Officer | SSale | −18.4K | $34.17 | −$630.0K | −41.2%26.3K after | 4 lots |
| Mar 24, 2022 (view filing) | Mar 22-23 | 2 days | Davis Aaron I.Director | PPurchase | +50.0K | $32.51 | +$1.63M | +1.6%3.19M after | 4 lots |
| Apr 19, 2022 (view filing) | Apr 18 | 1 day | Detheux MichelChief Executive Officer | SSale | −11.5K | $31.87 | −$366.5K | −30.5%26.3K after | 2 lots |
| May 2, 2022 (view filing) | Apr 28-May 2 | 4 days | Davis Aaron I.Director | SSale | −375.0K | $27.32 | −$10.2M | −11.7%2.82M after | 5 lots |
| May 11, 2022 (view filing) | May 9-11 | 2 days | Davis Aaron I.Director | SSale | −663.0K | $21.04 | −$14.0M | −23.5%2.15M after | 6 lots |
| Jun 10, 2022 (view filing) | Jun 8-9 | 2 days | Hallal DavidDirector | SSale | −29.6K | $20.17 | −$597.2K | −100.0%0 after | 4 lots |
| Aug 25, 2023 (view filing)9:28 PM ET | Aug 23 | 2 days | Lewis Joseph and 3 othersOther: See remarks | SSale | −350.0K | $16.26 | −$5.69M | −16.2%1.80M after | 3 lots |
| Oct 12, 2023 (view filing) | Oct 12 | Same day | Gall MatthewChief Financial Officer | PPurchase | +5.00K | $8.37 | +$41.9K | +34.7%19.4K after | |
| May 14, 2024 (view filing)9:06 PM ET | May 10 | 4 days | RA Capital Healthcare Fund LP and 3 othersOther: Former 10% Owner | PPurchase | +5.71M | $17.50 | +$100.0M | –5.71M after | Derivative |
| Nov 19, 2024 (view filing) | Nov 19 | Same day | Gall MatthewChief Financial Officer | PPurchase | +5.00K | $7.73 | +$38.6K | +8.3%65.4K after | |
| May 15, 2025 (view filing)5:32 PM ET | May 13 | 2 days | Evnin Luke and 8 othersOther: Former 10% Owner | SSale | −630.2K | $8.06 | −$5.08M | −23.0%2.11M after | |
| May 15, 2025 (view filing)5:33 PM ET | May 13 | 2 days | MPM Bioventures 2018, L.P. and 2 othersOther: Former 10% Owner | SSale | −630.2K | $8.06 | −$5.08M | −23.0%2.11M after | Duplicate filing |
| May 15, 2025 (view filing)5:34 PM ET | May 13 | 2 days | Gadicke Ansbert and 3 othersOther: Former 10% Owner | SSale | −1.03M | $8.06 | −$8.32M | −23.0%3.45M after | |
| May 16, 2025 (view filing) | May 14-15 | 2 days | EcoR1 Capital, LLC10% Owner | PPurchase | +4.96M | $7.80 | +$38.7M | +86.5%10.7M after | 2 lots |
| Jun 6, 2025 (view filing) | Jun 4-6 | 2 days | Hallal DavidDirector | SSale | −114.7K | $10.15 | −$1.16M | −100.0%0 after | 3 lots10b5-1 |
| Jun 6, 2025 (view filing) | Jun 4-6 | 2 days | Detheux MichelChief Executive Officer | SSale | −25.2K | $10.15 | −$255.9K | −15.6%135.9K after | 3 lots10b5-1 |
| Jun 6, 2025 (view filing) | Jun 4-6 | 2 days | Detheux MichelChief Executive Officer | SSale | −131.6K | $10.15 | −$1.34M | −100.0%0 after | 3 lots10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9-10 | 2 days | Detheux MichelChief Executive Officer | SSale | −16.8K | $10.03 | −$168.4K | −11.0%135.9K after | 2 lots10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9-10 | 2 days | Detheux MichelChief Executive Officer | SSale | −87.8K | $10.02 | −$879.8K | −100.0%0 after | 2 lots10b5-1 |